FI845095L - Aminoimidazolonderivat saosom histamin-h2-antagonister. - Google Patents

Aminoimidazolonderivat saosom histamin-h2-antagonister.

Info

Publication number
FI845095L
FI845095L FI845095A FI845095A FI845095L FI 845095 L FI845095 L FI 845095L FI 845095 A FI845095 A FI 845095A FI 845095 A FI845095 A FI 845095A FI 845095 L FI845095 L FI 845095L
Authority
FI
Finland
Prior art keywords
histamine
antagonister
aminoimidazolone
saosom
derivatives
Prior art date
Application number
FI845095A
Other languages
English (en)
Finnish (fi)
Other versions
FI845095A0 (fi
Inventor
Thomas Henry Brown
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI845095L publication Critical patent/FI845095L/fi
Publication of FI845095A0 publication Critical patent/FI845095A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI845095A 1983-04-27 1984-12-21 Aminoimidazolonderivat saosom histamin-h2-antagonister. FI845095A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838311443A GB8311443D0 (en) 1983-04-27 1983-04-27 Chemical compounds
PCT/GB1984/000127 WO1984004304A1 (en) 1983-04-27 1984-04-13 Aminoimidazolone derivatives as histamine h2-antagonists

Publications (2)

Publication Number Publication Date
FI845095L true FI845095L (fi) 1984-12-21
FI845095A0 FI845095A0 (fi) 1984-12-21

Family

ID=10541762

Family Applications (1)

Application Number Title Priority Date Filing Date
FI845095A FI845095A0 (fi) 1983-04-27 1984-12-21 Aminoimidazolonderivat saosom histamin-h2-antagonister.

Country Status (17)

Country Link
US (1) US4567176A (xx)
EP (1) EP0132914B1 (xx)
JP (1) JPS60501207A (xx)
KR (1) KR840008330A (xx)
AT (1) ATE34978T1 (xx)
DE (1) DE3471929D1 (xx)
ES (1) ES531933A0 (xx)
FI (1) FI845095A0 (xx)
GB (1) GB8311443D0 (xx)
GR (1) GR81941B (xx)
HU (1) HUT34744A (xx)
IL (1) IL71639A0 (xx)
NO (1) NO845172L (xx)
PT (1) PT78498B (xx)
WO (1) WO1984004304A1 (xx)
ZA (1) ZA843088B (xx)
ZW (1) ZW6784A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
TW221689B (xx) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
GB9611046D0 (en) * 1996-05-25 1996-07-31 Wivenhoe Techn Ltd Pharmacological compounds
US7423147B2 (en) 2004-03-31 2008-09-09 Janssen Pharmaceutical, N.V. Pyridine compounds as histamine H3 modulators
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CA2706328C (en) 2007-11-20 2016-04-19 Janssen Pharmaceutica N.V. Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN151188B (xx) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
GR79384B (xx) * 1982-08-20 1984-10-22 Hoechst Uk Ltd

Also Published As

Publication number Publication date
ES8505668A1 (es) 1985-06-01
WO1984004304A1 (en) 1984-11-08
EP0132914B1 (en) 1988-06-08
PT78498B (en) 1986-06-02
PT78498A (en) 1984-05-01
IL71639A0 (en) 1984-07-31
DE3471929D1 (de) 1988-07-14
HUT34744A (en) 1985-04-28
ATE34978T1 (de) 1988-06-15
GR81941B (xx) 1984-12-12
NO845172L (no) 1984-12-21
ZW6784A1 (en) 1985-04-17
US4567176A (en) 1986-01-28
KR840008330A (ko) 1984-12-14
EP0132914A2 (en) 1985-02-13
FI845095A0 (fi) 1984-12-21
ZA843088B (en) 1985-02-27
EP0132914A3 (en) 1985-12-27
ES531933A0 (es) 1985-06-01
GB8311443D0 (en) 1983-06-02
JPS60501207A (ja) 1985-08-01

Similar Documents

Publication Publication Date Title
FI845095A0 (fi) Aminoimidazolonderivat saosom histamin-h2-antagonister.
SE8303913L (sv) Heterocykliska foreningar
DE3476541D1 (de) Aminopyrimidinone derivatives as histamine h2-antagonists
FI864737A0 (fi) Nya basiskt substituerade pyridinfoereningar, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI842432A (fi) Amidinderivat av 2-substituerad 4-fenyl-imidazoler, foerfarande foer deras framstaellning och deras farmaceutiska anvaendning.
ES8602764A1 (es) Un procedimiento para preparar derivados de tiadiazina
JPS5677277A (en) Guanidine compound* its manufacture and composition containing it
EP0140466A3 (en) Pyrimidinone derivatives, process for their preparation, and their pharmaceutical use
ES8201994A1 (es) Procedimiento para la obtencion de nuevos derivados piridi- nicos de interes farmacologico
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: SMITH KLINE & FRENCH LABORATORIES